Accelerate Diagnostics, Inc. (AXDX)
USD 1.2
(4.35%)
USD 1.2
(4.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 39.22 Million USD | -49.42% |
| 2022 | 77.54 Million USD | -30.22% |
| 2021 | 111.11 Million USD | -25.92% |
| 2020 | 149.98 Million USD | 11.87% |
| 2019 | 134.07 Million USD | 11.66% |
| 2018 | 120.07 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 13 Thousand USD | -91.88% |
| 2014 | 160 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 42.41 Million USD | 4.94% |
| 2024 Q1 | 40.41 Million USD | 3.05% |
| 2023 FY | 39.22 Million USD | -49.42% |
| 2023 Q1 | 78.03 Million USD | 0.64% |
| 2023 Q2 | 36.57 Million USD | -53.14% |
| 2023 Q4 | 39.22 Million USD | 7.25% |
| 2023 Q3 | 36.57 Million USD | 0.0% |
| 2022 Q1 | 118.97 Million USD | 7.07% |
| 2022 FY | 77.54 Million USD | -30.22% |
| 2022 Q4 | 77.54 Million USD | 0.83% |
| 2022 Q3 | 76.9 Million USD | -30.7% |
| 2022 Q2 | 110.97 Million USD | -6.72% |
| 2021 Q3 | 113.71 Million USD | -27.06% |
| 2021 Q4 | 111.11 Million USD | -2.29% |
| 2021 FY | 111.11 Million USD | -25.92% |
| 2021 Q1 | 152.89 Million USD | 1.94% |
| 2021 Q2 | 155.9 Million USD | 1.97% |
| 2020 Q3 | 147.55 Million USD | 2.41% |
| 2020 Q4 | 149.98 Million USD | 1.65% |
| 2020 Q1 | 136.63 Million USD | 1.91% |
| 2020 FY | 149.98 Million USD | 11.87% |
| 2020 Q2 | 144.07 Million USD | 5.44% |
| 2019 Q2 | 125.29 Million USD | 1.91% |
| 2019 Q3 | 131.32 Million USD | 4.81% |
| 2019 FY | 134.07 Million USD | 11.66% |
| 2019 Q4 | 134.07 Million USD | 2.09% |
| 2019 Q1 | 122.94 Million USD | 2.39% |
| 2018 Q1 | 99.16 Million USD | 0.0% |
| 2018 FY | 120.07 Million USD | 0.0% |
| 2018 Q4 | 120.07 Million USD | 1.97% |
| 2018 Q3 | 117.75 Million USD | 1.95% |
| 2018 Q2 | 115.49 Million USD | 16.48% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 Q2 | 87 Thousand USD | -29.84% |
| 2015 Q1 | 124 Thousand USD | -22.5% |
| 2015 Q4 | 13 Thousand USD | -74.0% |
| 2015 FY | 13 Thousand USD | -91.88% |
| 2015 Q3 | 50 Thousand USD | -42.53% |
| 2014 FY | 160 Thousand USD | 0.0% |
| 2014 Q1 | 267 Thousand USD | 0.0% |
| 2014 Q3 | 196 Thousand USD | -15.52% |
| 2014 Q4 | 160 Thousand USD | -18.37% |
| 2014 Q2 | 232 Thousand USD | -13.11% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 92.76% |
| Nemaura Medical Inc. | 20.03 Million USD | -95.805% |
| NeuroPace, Inc. | 72.39 Million USD | 45.825% |
| LENSAR, Inc. | 2.3 Million USD | -1598.571% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -433.896% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -2358.934% |
| Apyx Medical Corporation | 38.5 Million USD | -1.867% |
| Cutera, Inc. | 431.91 Million USD | 90.919% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -150.88% |
| BioSig Technologies, Inc. | 452 Thousand USD | -8576.991% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 97.668% |
| Axonics, Inc. | 27.61 Million USD | -42.014% |
| IRIDEX Corporation | 2.74 Million USD | -1328.259% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 50.482% |
| TELA Bio, Inc. | 42.78 Million USD | 8.322% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -10528.726% |
| RxSight, Inc. | 3.01 Million USD | -1202.125% |
| Align Technology, Inc. | 96.96 Million USD | 59.554% |
| INVO Bioscience, Inc. | 8.68 Million USD | -351.658% |
| electroCore, Inc. | 626 Thousand USD | -6165.176% |
| Telesis Bio, Inc. | 34.38 Million USD | -14.078% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -281.845% |
| Quipt Home Medical Corp. | 98.94 Million USD | 60.361% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -35.069% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1570.358% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -157.096% |
| Dynatronics Corporation | 6.68 Million USD | -486.428% |
| Modular Medical, Inc. | 1.19 Million USD | -3195.798% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -14869.466% |
| Talis Biomedical Corporation | 19.66 Million USD | -99.41% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -2773.176% |
| InMode Ltd. | 9.01 Million USD | -334.956% |
| Envoy Medical, Inc. | 404 Thousand USD | -9607.921% |
| Bruker Corporation | 1.37 Billion USD | 97.157% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -68707.018% |
| DexCom, Inc. | 2.59 Billion USD | 98.488% |
| Nexalin Technology, Inc. | 4463.00 USD | -878681.089% |
| PAVmed Inc | 48.72 Million USD | 19.507% |
| Viveve Medical, Inc. | 5.34 Million USD | -633.221% |
| Cerus Corporation | 95.99 Million USD | 59.145% |
| Movano Inc. | 252 Thousand USD | -15463.492% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -18.225% |
| Nexalin Technology, Inc. | 4463.00 USD | -878681.089% |
| IceCure Medical Ltd | 599 Thousand USD | -6447.579% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 90.565% |
| enVVeno Medical Corporation | 1.4 Million USD | -2697.432% |
| 908 Devices Inc. | 5.94 Million USD | -559.714% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -181.328% |
| Orthofix Medical Inc. | 134.19 Million USD | 70.775% |
| Surmodics, Inc. | 29.4 Million USD | -33.379% |
| Nuwellis, Inc. | 981 Thousand USD | -3897.961% |
| Outset Medical, Inc. | 136.18 Million USD | 71.202% |
| Venus Concept Inc. | 79.69 Million USD | 50.789% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 69.79% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 44.213% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -367.127% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -4070.938% |
| Inogen, Inc. | 21.92 Million USD | -78.899% |
| IRadimed Corporation | 2.04 Million USD | -1819.685% |
| MaxCyte, Inc. | 18.74 Million USD | -109.251% |
| Pulmonx Corporation | 41.42 Million USD | 5.321% |
| PAVmed Inc. | 48.72 Million USD | 19.507% |
| iCAD, Inc. | 461 Thousand USD | -8407.592% |
| OrthoPediatrics Corp. | 23.76 Million USD | -65.067% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -1864.438% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -7871.691% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -21168.98% |
| SI-BONE, Inc. | 38.99 Million USD | -0.585% |
| Semler Scientific, Inc. | 70 Thousand USD | -55928.571% |
| Beyond Air, Inc. | 17.83 Million USD | -119.88% |
| FONAR Corporation | 41.67 Million USD | 5.893% |
| AxoGen, Inc. | 69.29 Million USD | 43.399% |
| Biotricity, Inc. | 23.87 Million USD | -64.246% |
| Cytosorbents Corporation | 18.31 Million USD | -114.163% |
| ZimVie Inc. | 521.92 Million USD | 92.486% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 22.144% |
| Inari Medical, Inc. | 32.04 Million USD | -22.383% |
| UFP Technologies, Inc. | 46.03 Million USD | 14.808% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -1864.438% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -1177.083% |
| Sight Sciences, Inc. | 35.41 Million USD | -10.747% |
| Insulet Corporation | 1.44 Billion USD | 97.293% |
| Profound Medical Corp. | 7.9 Million USD | -396.432% |
| Bioventus Inc. | 409.47 Million USD | 90.422% |
| InspireMD, Inc. | 1.59 Million USD | -2358.934% |
| BrainsWay Ltd. | 471 Thousand USD | -8226.964% |
| BIOLASE, Inc. | 17.91 Million USD | -118.984% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -3684.48% |
| Tenon Medical, Inc. | 1.17 Million USD | -3243.564% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -3814.172% |
| CVRx, Inc. | 30.61 Million USD | -28.116% |
| AdaptHealth Corp. | 2.29 Billion USD | 98.291% |
| Sintx Technologies, Inc. | 4.24 Million USD | -823.91% |
| Acutus Medical, Inc. | 38.47 Million USD | -1.926% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -1865.915% |
| NanoVibronix, Inc. | 5000.00 USD | -784300.0% |
| Quanterix Corporation | 41.46 Million USD | 5.412% |
| LivaNova PLC | 640.4 Million USD | 93.876% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -1211.457% |
| Varex Imaging Corporation | 469.5 Million USD | 91.646% |
| Vivani Medical, Inc. | 20.69 Million USD | -89.505% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1570.358% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -4908.94% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 95.801% |
| TransMedics Group, Inc. | 515.94 Million USD | 92.398% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -1960.956% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -16182.237% |
| Spectral AI, Inc. | 1.28 Million USD | -2942.669% |
| Hyperfine, Inc. | 185 Thousand USD | -21100.0% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 79.597% |
| Biomerica, Inc. | 785 Thousand USD | -4896.178% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -8625.58% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -10496.993% |
| Silk Road Medical, Inc | 84.63 Million USD | 53.659% |